Brexpiprazole for the treatment of schizophrenia
Brexpiprazole (OPC-34712) is a novel serotonin-dopamine activity modulator, which has recently been approved by the U.S Food and Drug Administration for the treatment of schizophrenia. The aim of this paper is to systematically synthesize all data of the efficacy, safety and tolerability of Brexpipr...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Published: |
Taylor & Francis
2016
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/18792/ http://dx.doi.org/10.1586/14737175.2016.1129901 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|